Lupin acquires UK-based firm for 12.3 million pounds

Lupin has acquired UK-based Renascience Pharma for £12.3 million, enhancing its branded medicine portfolio. The acquisition allows Lupin to expand in the UK market with Renascience's products for infectious diseases, ear pain, and cardiovascular and renal treatment. This move supports Lupin's mission to provide accessible healthcare solutions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/NXT8w9t
via IFTTT